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The intention of Dutch general
practitioners to offer vaccination against
pneumococcal disease, herpes zoster and
pertussis to people aged 60 years and
older
Birthe A. Lehmann1*, Renske Eilers1,2, Liesbeth Mollema1, José Ferreira1 and Hester E. de Melker1
Abstract
Background: Increasing life expectancy results in a larger proportion of older people susceptible to vaccine preventable
diseases (VPDs). In the Netherlands, influenza vaccination is routinely offered to people aged 60 years and older.
Vaccination against pneumococcal disease, herpes zoster and pertussis is rarely used. These vaccines will be evaluated by
the Dutch Health Council and might be routinely offered to older people in the near future. Possible expansion of the
program depends partly on the willingness of general practitioners (GPs) to endorse additional vaccinations. In this study,
we assessed predictors of GPs’ attitude and intention to vaccinate people aged 60 years and older.
Methods: GPs (N = 12.194) were invited to fill in an online questionnaire consisting of questions about social cognitive
factors that can influence the willingness of GPs to vaccinate people aged 60 years and older, including underlying
beliefs, practical considerations of adding more vaccines to the national program, demographics, and GPs’ patient
population characteristics. The questionnaire was filled in by 732 GPs.
Results: GPs were positive both about vaccination as a preventive tool and the influenza vaccination program, but
somewhat less positive about expanding the current program. Prediction analysis showed that the intention of GPs to
offer additional vaccination was predicted by their attitude towards offering additional vaccination, towards vaccination
as a preventive tool, towards offering vaccination during an outbreak and on GPs opinion regarding suitability to offer
additional vaccination (R2 = 0.60). The attitude of GPs towards offering additional vaccination was predicted by the
perceived severity of herpes zoster and pneumonia, as well as the perceived incidence of herpes zoster. Severity of
diseases was ranked as important argument to recommend vaccination, followed by effectiveness and health benefits
of vaccines.
Conclusion: Providing GPs with evidence-based information about the severity and prevalence of diseases, and
effectiveness and health benefits of the vaccines, together with an active role of GPs in informing older people about
vaccines, could modify the intention towards additional vaccination of people 60 years and older.
Keywords: General practitioners, Older people, Vaccination, Influenza, Pneumonia, Herpes zoster, Pertussis, Social
cognitive predictors
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Background
Life expectancy has increased around the world, result-
ing in a larger proportion of older people in the popula-
tion. It is estimated that by 2060, 28.4% of the
population in the EU will consist of people older than
65 years of age, which would be an increase of almost
10% since 2014 [1]. Age-dependent deterioration of the
immune system, called immunosenescence, together
with general frailty and possible co-morbidity make
older people particularly susceptible to infectious dis-
eases [2, 3]. Infectious diseases play an important role in
the disease burden of older people and an increased
social engagement among community-dwelling older
adults might additionally increase the risks of transmis-
sion [4–6]. Moreover, immunity – vaccine and naturally
acquired – can wane over time which makes reactivation
of certain latent viruses possible [7]. Successful (re)vac-
cination of older people against vaccine preventable dis-
eases (VPDs) may be an important preventive strategy
for reducing the disease burden and health care costs in
the aging population. Vaccines against influenza,
pneumococcal disease, herpes zoster and pertussis are
available, but only influenza is routinely offered to
people aged 60 years and older in the Netherlands [8].
The diseases occur frequently among older people in the
Netherlands [9] and vaccination against pneumococcal
disease and herpes zoster is amongst others routinely of-
fered to people aged 65 and 70 years of age respectively
in the UK, while vaccination against pertussis is amongst
others offered to people aged 65 in Belgium [10]. These
vaccines are currently also being evaluated by the Dutch
Health Council on their suitability to be routinely
offered to older people in the near future.
As is the case in many European countries, general
practitioners (GPs) carry out the national influenza vac-
cination program by selecting and inviting eligible pa-
tients from their registries and administering vaccination
in the Netherlands. Moreover, previous research showed
that the advice of the GP to get vaccinated was men-
tioned as the most important external influence on
acceptance of vaccination by older people [11]. For
this reason, they are the most likely choice in the
Netherlands to administer vaccination when imple-
menting new vaccination strategies for older people
and to offer vaccination against infectious diseases
other than influenza vaccination to elderly popula-
tions. Consequently, the feasibility of expanding the
current program also depends on the willingness of
GPs to organize and endorse new vaccination strat-
egies. However, little is known about Dutch GPs’ atti-
tude towards expanding the program for elderly
people with additional vaccines, whether they would
be willing to offer and administer those vaccines and
under which circumstances.
Recently, a qualitative study was conducted in the
Netherlands [12] exploring the attitude of GPs towards
vaccinating older people and towards adding pneumo-
coccal, herpes zoster and pertussis vaccination to the
current program. In an effort to quantify the findings of
this qualitative study, we conducted a cross-sectional
study investigating the relative and combined strength
of the identified factors and underlying beliefs in
explaining the intention of GPs to vaccinate people




In January 2015, all Dutch GPs (12.194 registered) work-
ing in 5068 general practices were invited to fill in an
online questionnaire about the factors that influence
their willingness to vaccinate people aged 60 years and
older against infectious diseases other than influenza.
GPs were asked to participate via a link in an e-mail sent
by the National Influenza Prevention Program Foun-
dation (SNPG), which coordinates the logistics of the
influenza vaccination program (i.e. delivering vaccines
to practices). Of the invited GPs 723 (6.0%) partici-
pated in this study. This type of study does not
require ethics approval in the Netherlands because it
does not fall under the Medical Research Involving
Human Subjects act [13].
The questionnaire
The questionnaire used for this study was based on an
interview study among ten Dutch GPs, which explored
GPs’ attitude towards vaccination of older people in gen-
eral and potential future candidates for inclusion in the
current influenza vaccination program for people aged
60 years and older [12]. The questionnaire consisted of
37 questions/statements about social cognitive factors,
underlying beliefs, practical considerations, demograph-
ics, and characteristics of the GPs’ patient population.
Variables were measured on 7-point Likert scales ran-
ging from 1 = totally disagree to 7 = totally agree, unless
otherwise indicated. Items measuring the same under-
lying construct were averaged into one single construct
when internal consistency was sufficient (Cronbach’s
alpha α > 0.60 or Pearson correlation coefficient
r > 0.50). Items were recoded so that all effects pointed
to the same direction. See Table 1 for an overview of the
constructs and their internal consistency.
In addition to questions about their intention to vac-
cinate patients in their 60s against other infectious
diseases than influenza, GPs were asked about their
intention to recommend vaccination against pneumo-
coccal disease, herpes zoster and pertussis to healthy
people in their 60s and their intention to recommend
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vaccination of these diseases to people in their 60s with
co-morbidity with separate items (see Table 1).
Moreover, GPs were asked to rank six arguments
for offering vaccination to older patients. These argu-
ments were identified as main arguments in the quali-
tative study preceding this cross-sectional study [12].
The arguments concerned health benefits for the indi-
vidual, the severity of an infectious disease, vaccine
effectiveness, side-effects of a vaccine, the outbreak of
an infectious disease, and cost-effectiveness of vaccin-
ation. Furthermore, GPs were asked which of the pro-
posed vaccines they considered to have the highest
probability of being included in a program (pneumo-
coccal/herpes zoster/pertussis vaccination/none of the
above).
Next to that, practical considerations about offering
additional vaccination were measured by asking about
GPs’ suitability to apply additional vaccination, the im-
portance of reimbursement for the implementation of a
vaccination program, and preference for offering and ad-
ministering additional vaccination at the same time as
influenza vaccination, in the same national program, or
outside of a national program.
Demographic variables were age, sex, and kind of prac-
tice (own practice, shared practice, integrated in health
care setting, academic setting). Characteristics of GPs’ pa-
tient population were number of patients registered in the
practice, an estimate of the proportion of patients aged
60 years and older registered in the practice, and the
perceived incidence of influenza, pneumonia, herpes
zoster, and pertussis among patients aged 60 years
and older in their practice (1 = never; 7 = very often).
See Additional file 1 for the entire questionnaire.
Data analysis
Following a descriptive analysis of the sample (frequen-
cies), univariate associations between intention and so-
cial cognitive factors, beliefs and practical considerations
were tested with Spearman’s correlation test. To control
for the false discovery rate (FDR) in multiple testing, the
Benjamini-Hochberg [14] procedure was applied. Fur-
thermore, paired z-tests were used to compare the
intention to recommend vaccination against pneumo-
coccal disease, herpes zoster and pertussis to people
in their 60s when they are healthy and when they
have co-morbidities.
Table 1 Overview of constructs measured by the online survey
Variable Number of items Reliability Example question
Intention 3 α = .88 I would be willing to vaccinate people aged 60 years and older
against infectious diseases other than influenza.
Attitude 2 r = .64 I think vaccination as a preventive tool is: 1 = not very useful;
7 = very useful.
Attitude additional vaccination 1 n.a. Offering additional vaccination other than influenza vaccination to
people aged 60 years and older is necessary.
Attitude vaccination 80+ 1 n.a. Offering people 80 years and older some form of vaccination
is still useful.
Attitude outbreak 1 n.a. Vaccinating people 60 years and older with or without co-morbidities
during an outbreak of an infectious disease is always useful.
Perceived severity (per infectious disease) 4 n.a. How serious do you think are the different diseases for people aged
60 years and older? Influenza/ herpes zoster/ pneumonia/ pertussis:
1 = not severe at all; 7 = very severe. These are four separate items.
Selection comorbidity over age 3 α = .81 Vaccinating people on the basis of co-morbidities is favored over
vaccinating people on the basis of age, irrespective of the infectious
disease.
Prevention 1 n.a. In general, prevention of illness has the preference over cure.
Prevention mortality 1 n.a. Additional vaccines should primarily be focused on the prevention
of death.
Prevention morbidity 1 n.a. Additional vaccines should primarily be focused on the prevention
of illness
Usefulness health benefits 1 n.a. In the consideration to offer vaccination, individual health benefits
are more important than cost-effectiveness on the population level.
Intention (per infectious disease) 3 n.a. I would recommend healthy people in their 60s to get vaccinated
against pneumococcal disease/ herpes zoster/ pertussis. These are
three separate items.
Intention comorbidity (per infectious disease) 3 n.a. I would recommend people in their 60s who have a comorbidity to
get vaccinated against pneumococcal disease/ herpes zoster/ pertussis.
These are three separate items.
n.a., not applicable
Lehmann et al. BMC Geriatrics  (2017) 17:122 Page 3 of 10
In order to determine which factors contributed most to
the prediction of GPs intention to offer additional vaccin-
ation and their attitude towards offering additional vaccin-
ation other than influenza vaccination to older people,
prediction analyses were performed using randomForest
[15]. RandomForest is an algorithm that predicts an out-
come (intention, attitude) of an individual by means of
several predictor variables (in our case social cognitive
factors, beliefs, practical considerations, demographics
and patient population characteristics). The relative im-
portance of the predictor variables is assessed by deter-
mining how much the prediction error increases as a
result of random permutation of the data for that variable.
If a variable does not contribute to the prediction of the
outcome, error estimates from the randomly permuted
dataset will be about the same as for the original dataset,
while prediction errors increase by permuting the data on
variables that are crucial for the prediction of an outcome.
Results
Response and descriptive statistics
See Table 2 for demographics and patient population
characteristics. Of the total sample, 463 (63.3%) were
male, while 55% of the registered GPs were male.
Participants had a mean age of 51.2 years (range 30 to
70), which was comparable to the mean age of the over-
all Dutch GP population (48.9 years). Comparisons with
the total population of registered GPs are based on records
from the general practitioners' registration poll of 2014
[16]. Most GPs reported to be part of a shared practice with
several GPs (43.5%) or were working in their own practice
(34.8%), instead of in a practice integrated into another
health care setting (21.2%) or an academic setting (0.3%).
On average, the number of patients registered in the prac-
tices was 3136 (range 220 to 17,000), with an estimated
average of 750 patients above the age of 60 (range 0–4000).
The average perceived incidence of the four diseases on a
seven point Likert scale was 4.7 for pneumonia, 4.6 for in-
fluenza, 4.2 for herpes zoster, and 2.4 for pertussis. GPs
ranked the severity of the infectious disease most often as
the most important factor for recommending vaccination
to people in their 60s (37.6% ranked it as most important),
followed by the effectiveness of the vaccine (26.5%) and the
expected health benefits for the individual (20.8%). Cost-
effectiveness was the least often reported factor for recom-
mending vaccination (43.2% ranked it as least important),
followed by the side-effects of the vaccine (17.9%) and dur-
ing an outbreak of the infectious disease (17.8%). Regarding
the question of which vaccine candidate had the highest
chance of being included in a vaccination program, 74.6%
GPs chose pneumococcal vaccine, 10.5% herpes zoster vac-
cine, 4.2% pertussis vaccine, and 10.7% indicated that they
considered that none of those vaccine candidates was likely
to be included. The attitude towards vaccination as a
preventive tool in general was significantly more positive
than the attitude towards offering additional vaccination
(M = 5.43 vs. M = 4.22, t(731) = 21.425, p < .001).
Correlations between intention and attitude with items of
the questionnaire
Here we report univariate associations of intention and atti-
tude towards offering additional vaccination with the social
cognitive factors, beliefs and practical considerations. In
order to avoid false positive results we control the FDR at
5% (Table 3). In total, 134 associations among the 190 asso-
ciations studied are declared significant at an FDR ≤ 5%,
which corresponds to about seven or fewer false discoveries
among the 134 associations (0.05*134 = 6.7). Both intention
and attitude to offer additional vaccination showed
significant univariate associations with almost all so-
cial cognitive factors and practical considerations con-
sidered. All associations were positive, except for the
associations with selection based on co-morbidity in-
stead of age, the belief that adding additional vaccin-
ation will complicate the organization of vaccination,
and the belief that additional vaccination should
primarily be based on the prevention of death. See
Additional file 2 for all 190 associations.




(N = 12.194) in 2014
Gender
Male 463 (63.3%) 55%
Female 269 (36.7%) 45%
Age (mean, SD) 51.2 (8.7) 48.9
Practice
Own practice 34.8% 28%
Shared practice 43.5% 33%
Integrated in health care setting 21.2% n.a.
Academic setting 0.3% n.a.
Other 0.1% 39%
Work experience
(in years, mean, SD)
20.2 (8.6) n.a.
Total number of patients
(mean, SD)
3136 (1631) n.a.
Number of patients 60+
(mean, SD)
750 (500) n.a.
Proportion of patients 60+
(mean, SD)
.25 (.14) n.a
Perceived prevalence (1 = never; 7 = very often, mean)
Influenza 4.6 n.a.
Herpes zoster 4.2 n.a.
Pneumonia 4.7 n.a.
Pertussis 2.4 n.a.
n.a., data not available
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Effect of co-morbidity on intention to vaccinate
There were significant differences between the scores for
intention to recommend vaccination for healthy people
aged 60 (pneumonia M = 4.1, SD = 1.7; herpes zoster
M = 3.3, SD = 1.7; pertussis M = 3.3, SD = 1.5) and for
people aged 60 with co-morbidities (pneumonia M = 5.3,
SD = 1.4; herpes zoster M = 4.4, SD = 1.6; pertussis
M = 4.3, SD = 1.6): the p-values of the z-tests are all well
below 0.001 for pneumonia, herpes zoster and pertussis.
The results suggest that the presence of co-comorbidities
increases the intention of GPs to recommend vaccination
against the three infectious diseases to people in their 60s.
Intention with or without co-morbidities was highest for
pneumonia, followed by herpes zoster and pertussis.
Prediction analysis
Due to missing values, the randomForest algorithm was
performed for 694 participants (see Figs. 1 and 2). The
Table 3 Selected pairwise associations for intention and attitude extra vaccination
Outcome variable (mean, SD) Predictor variable Mean SD Spearman correlation
Intention (4.68, 1.34) Attitude extra vaccination 4.22 1.66 0.66
Attitude 5.43 1.16 0.56
Attitude vaccination outbreak 4.01 1.58 0.51
Fit GP 5.57 1.46 0.48
Perceived severity pneumonia 5.76 .85 0.46
Attitude vaccination 80 4.88 1.52 0.45
Perceived severity herpes zoster 4.54 1.29 0.41
Prevention morbidity 5.31 1.37 0.40
Selection comorbidity over age 5.10 1.23 −0.37
Perceived severity flu 4.77 1.22 0.36
Perceived severity pertussis 4.55 1.25 0.35
Prevention 6.02 .99 0.31
Difficult organisation 3.66 1.85 −0.25
Outside program 4.88 1.47 0.20
Reimbursement 6.51 .68 0.16
One program 5.53 1.32 0.15
Prevention mortality 4.31 1.78 −0.10
Attitude extra vaccination (4.22, 1.66) Intention 4.68 1.34 0.66
Attitude 5.43 1.16 0.46
Perceived severity pneumonia 5.76 .85 0.42
Attitude vaccination outbreak 4.01 1.58 0.40
Attitude vaccination.80 4.88 1.52 0.40
Selection comorbidity over age 5.10 1.23 −0.40
Perceived severity herpes zoster 4.54 1.29 0.39
Prevention morbidity 5.31 1.37 0.33
Fit GP 5.57 1.46 0.32
Perceived severity pertussis 4.55 1.25 0.31
Perceived severity flu 4.77 1.22 0.30
Prevention 6.02 .99 0.29
Outside program 4.88 1.47 0.20
Difficult organisation 3.66 1.85 −0.19
Prevention mortality 4.31 1.78 −0.16
Reimbursement 6.51 .68 0.12
One program 5.53 1.32 0.12
False discovery rate (FDR) ≤ 5%, all correlations have p ≤ .001
SD standard deviation
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variables included in the prediction analysis with
intention to offer additional vaccination other than influ-
enza as outcome explained 60% of the variance in
intention. Attitude towards offering additional vaccin-
ation other than influenza vaccination to older people,
the general attitude towards vaccination as a preventive
tool, the practical consideration of GPs being suitable to
administer additional vaccination, and the attitude
towards offering older people vaccination during an out-
break of the infectious disease are among those with the
largest predictive value for the intention to vaccinate
people aged 60 years and older against infectious dis-
eases other than influenza. The variables included in the
prediction analysis with attitude towards offering add-
itional vaccination as an outcome explained 39% of the
variance in attitude. Factors with the largest predictive
value for attitude include the selection of vaccination for
older individuals on the basis of co-morbidities instead
of age, general attitude towards vaccination as a prevent-
ive tool, the attitude towards offering people aged
80 years and older vaccination, the attitude towards of-
fering older people vaccination during an outbreak of
the infectious disease, and the perceived severity of her-
pes zoster and pneumonia, as well as the prevalence of
herpes zoster.
Discussion
This study found that the intention of GPs to offer add-
itional vaccination to people aged 60 years and older
other than influenza vaccination was mainly predicted
by their attitude towards offering additional vaccination,
their attitude towards vaccination as a preventive tool in
general, and their attitude towards offering vaccination
during the outbreak of an infectious disease. On average,
GPs seem to be positive about vaccination as a prevent-
ive tool in general, but a bit less positive about offering
additional vaccination to people aged 60 years and older.
Our findings further suggest that GPs are more willing
to recommend vaccination against pneumococcal dis-
ease, herpes zoster and pertussis to patients in their 60s
Fig. 1 Prediction of intention to offer additional vaccination to people aged 60 years and older other than influenza vaccination. MAE: mean absolute
error. %IncMSE percentage increase in mean absolute error
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when those patients have co-morbidities, with the most
positive intention for pneumococcal disease. The atti-
tude of GPs to offer additional vaccination was amongst
others predicted by the perceived severity of pneumo-
coccal disease and the perceived severity and prevalence
of herpes zoster. Research from the US, Australia and
Italy has also shown that GPs had a positive attitude to-
wards recommending influenza and pneumococcal vac-
cination to older patients and that these diseases were
perceived to be serious for older people [17–20]. More-
over, research from the United States has shown that
GPs recommend herpes zoster vaccination less often to
their older patients than they do influenza and pneumo-
coccal vaccination [21], despite the recognition of GPs
that herpes zoster can cause prolonged suffering among
older individuals [22]. This is in accordance with our
finding that most GPs indicate the pneumococcal vac-
cine as the one among the three vaccine candidates with
the highest chance to be added to the national program,
and that only few GPs consider herpes zoster vaccination
and pertussis vaccination for inclusion. This is also in line
with the estimated disease burden of the respective dis-
eases [23], as well as with the prioritization of Dutch older
adults, who had indicated the highest acceptance for
pneumococcal vaccination and the lowest for pertussis
vaccination [11]. Consequently, the intention of Dutch
GPs to offer additional vaccination to older people will
probably depend on their perceived severity of the dis-
eases and their disease burden. GPs ranked the severity of
an infectious disease most frequently as an important ar-
gument for offering vaccination to older people, followed
by the effectiveness of the vaccine, and the expected
health benefits for the individual. Cost-effectiveness
was ranked as the least important argument for offer-
ing vaccination. Side effects of the vaccine and the
outbreak of an infectious disease were also ranked
lower in the importance for the decision to offer vac-
cination. Previous research from the US had shown
that beliefs about vaccine effectiveness, the risk for
illness, and cost-effectiveness of a vaccine were strongly
Fig. 2 Prediction of attitude towards offering additional vaccination to people aged 60 years and older other than influenza vaccination. MAE:
mean absolute error. %IncMSE percentage increase in mean absolute error
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associated with the recommendation of pneumococcal
vaccination by GPs [17].
The selection of vaccination for older individuals
based on co-morbidities instead of age, also appeared as
one of the main predictors of the attitude of GPs to offer
additional vaccination to older people. Although it was
difficult to interpret its influence since it shows a
negative univariate association with attitude to offer
additional vaccination, we think that selection on co-
morbidity is preferred. The contradiction was very likely
due to the way the statement was framed: “Vaccinating
people on the basis of co-morbidities is favored over
vaccinating people on the basis of age, irrespective of the
infectious disease” contains a weighing up of two alter-
natives. In order to better understand this contradiction,
we presented this item as two separate statements to a
group of GPs (N = 99). Results showed that selection of
vaccination for older individuals on the basis of co-
morbidity was favored over selection on the basis of age.
Attitude to offer additional vaccination to people aged
60 years and older other than influenza was further pre-
dicted by their general attitude towards vaccination as a
preventive tool, as well as by their attitude towards offer-
ing vaccination to patients in their 80s and during the
outbreak of a disease.
Moreover, intention was predicted by whether GPs
think that they are the suitable professionals to offer
additional vaccination to older people. Considering the
importance of the role of GPs in expanding the current
vaccination program for older people, it is a positive sign
that they consider themselves suitable for offering and
applying additional vaccination. In the qualitative study
preceding this study, GPs explained that they were suit-
able to implement new vaccination strategies, because of
their successful implementation of the influenza vaccin-
ation program, their knowledge on the disease histories
of their patients, and their role as health educators that
are trusted by older patients [12].
Influenza vaccination uptake rates among older people
are suboptimal in Europe [24]. Previously reported bar-
riers to administering vaccination to adults have been a
lack of physicians’ knowledge about vaccination [25],
poor vaccine supply [26], cost of vaccinations [27], and
practice barriers, such as competing priorities in care es-
pecially in the presence of acute or chronic problems
[28, 29]. The most common barriers for vaccination up-
take among patients were a lack of knowledge about the
benefits of vaccination [30], concerns about vaccine
safety [31, 32] and when vaccination is not recom-
mended by physicians [11, 32, 33]. In the light of our
findings, it seems to be especially important to inform
GPs about available vaccines for older people and to
provide them with evidence-based information on the
incidence and severity of the targeted infectious diseases
among older people. The finding that GPs have a more
positive intention to offer pneumococcal, herpes zoster
and pertussis vaccination to older patients, when they
have a co-morbidity is in line with research showing that
co- and multi-morbidity lead to higher susceptibility to-
wards infectious diseases in older people [4]. However,
older age on its own also increases the incidence of
serious complications and mortality associated with
infection [4, 34, 35]. Identifying the influence of co-
morbidities on the disease burden of infectious diseases
poses methodological challenges [23] since data on the
occurrence of comorbidity is often missing. Policy ad-
visers should therefore clearly state evidence-based
implications, explaining why recommendation of vaccin-
ation is based on age rather than on co-morbidity. For
example, research has suggested that vaccination against
herpes zoster should be focused on specific age groups,
since the disease burden was relatively low for people
aged 50 years and older, but increased considerably for
people aged 75 years and older [23].
A limitation that should be mentioned is that the sur-
vey length was kept to a minimum and the variables
were for the most part measured by one single item,
which might have lowered measurement specificity. This
was done to achieve a higher response rate. Still, re-
sponse bias is likely with the low response rate of 6%
and we only have limited data to compare participating
GPs to the total population of Dutch GPs. Moreover,
generalization of the findings to other countries should
be treated with caution since vaccination policies, as well
as vaccination acceptance differ among countries [36].
Conclusions
In conclusion, GPs seem to be positive about offering at
least some of the additional vaccinations to older people,
when infectious diseases are perceived as severe and
prevalent. They also feel suitable to administer add-
itional vaccination. In order to ensure a positive attitude
of GPs towards informing about and administering add-
itional vaccinations to older people, they need to have
clear guidelines, including evidence-based information
about severity and incidence of the diseases, the effect-
iveness and health benefits of the vaccines, as well as
about advising vaccination based on high-risk groups.
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